Real World SB4 (Etanercept Biosimilar) Use in Patients With Psoriasis: Data from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
Por:
Egeberg, A, Girolomoni, G, Feldman, SR, Radtke, MA, Carrascosa, JM, Ghil, J, Keum, JW, Lee, J and Seo, H
Publicada:
1 mar 2020
Resumen:
Filiaciones:
Egeberg, A:
Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Copenhagen, Denmark
Girolomoni, G:
Univ Verona, Dept Med, Sect Dermatol & Venereol, Verona, Italy
Feldman, SR:
Wake Forest Univ, Bowman Gray Sch Med, Dept Dermatol, Winston Salem, NC 27101 USA
Radtke, MA:
Dermatologikum Hamburg Dermatol Practice, Hamburg, Germany
:
Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Barcelona, Spain
Ghil, J:
Samsung Bioepis Co Ltd, Incheon, South Korea
Keum, JW:
Samsung Bioepis Co Ltd, Incheon, South Korea
Lee, J:
Samsung Bioepis Co Ltd, Incheon, South Korea
Seo, H:
Samsung Bioepis Co Ltd, Incheon, South Korea
|